- Filed
- Apr 24, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 18, 2025 | 30.86M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $262.03M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $220.06M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $163.14M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $134.13M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $353.23M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $340.29M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $697.72M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $630.61M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $764.04M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $684.02M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.34B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.25B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 31.69M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $11.32M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$10.32M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $647.06M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $644.72M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.47 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.47 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $40.72M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $22.75M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $18.05M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $88.75M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $267.26M |
| Revenue | Q1 2025 · Mar 31, 2024 | $356.02M |